WallStSmart
CTXR

Citius Pharmaceuticals Inc

NASDAQ: CTXR · HEALTHCARE · BIOTECHNOLOGY

$0.53
-1.40% today

Updated 2026-11-16

Market cap
$14.69M
P/E ratio
—
P/S ratio
2.07x
EPS (TTM)
$-1.75
Dividend yield
—
52W range
$0 – $2
Volume
0.2M

Citius Pharmaceuticals Inc (CTXR) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$0.53
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20212022202320242025
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.